GSEA analysis showed that overexpressed of SLC1A4 participated in multiple carcinogenesis-associated signaling pathways and processes, including ubiquitin-mediated proteolysis, cell cycle, pancreatic cancer, lysosome, prostate cancer, RNA degradation, pathways in cancer and small cell lung cancer. Here, SLC1A4 is linked to pancreatic neoplasm.